Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED
02 1Medichem S.A.
03 1Astellas Pharma Inc.
04 1Aurobindo Pharma Limited
05 1DARMERICA, LLC
06 1Divi's Laboratories Limited
07 1Quimica Sintetica S.A.
08 1ScinoPharm Taiwan Ltd.
09 1Suven Pharmaceuticals Limited
10 1Swati Spentose Private Limited
11 1Unichem Laboratories Limited, India
12 1Zydus Lifesciences Limited
01 1Tamsulosin HCL
02 9Tamsulosin Hydrochloride
03 1Tamsulosin hydrochloride
04 1tamsulosin hydrochloride
01 7India
02 1Japan
03 2Spain
04 1Taiwan
05 1U.S.A
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-118
Start Marketing Date : 2020-01-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0073
Start Marketing Date : 2010-05-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12838-2788
Start Marketing Date : 2010-07-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-298
Start Marketing Date : 2024-01-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-024
Start Marketing Date : 2004-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53069-0860
Start Marketing Date : 2003-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-2074
Start Marketing Date : 2004-01-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52119-024
Start Marketing Date : 2024-01-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-018
Start Marketing Date : 2010-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65841-118
Start Marketing Date : 2018-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Tamsulosin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tamsulosin HCl, including repackagers and relabelers. The FDA regulates Tamsulosin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tamsulosin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tamsulosin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tamsulosin HCl supplier is an individual or a company that provides Tamsulosin HCl active pharmaceutical ingredient (API) or Tamsulosin HCl finished formulations upon request. The Tamsulosin HCl suppliers may include Tamsulosin HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Tamsulosin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tamsulosin HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tamsulosin HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tamsulosin HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tamsulosin HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tamsulosin HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tamsulosin HCl suppliers with NDC on PharmaCompass.
We have 12 companies offering Tamsulosin HCl
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
